Beijing Tiantan Biological Products Co., Ltd. provided earnings guidance for the year 2017. The Company predicts an increase of about RMB 913,870,000 in the net profit belonging to shareholders of listed company in 2017, with an increase of about 349% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations). The Company predicts an increase of RMB 918,760,000, with an increase of about 358% compared with the same period of the year before (reiterated and adjusted data). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by about RMB 164,550,000, with an increase of about 67% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations). The Company predicts an increase of RMB 164,550,000, with an increase of about 67% compared with the same period of the year before (reiterated and adjusted data).